The Intellectual Property and Science business of Thomson Reuters recently honoured Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year.
Avalanche Biotechnologies
Filter by:
Tags
- 23andMe
- 3M
- A1M Pharma
- Abcam
- AbClon
- Ablynx
- Accenture
- ACD Bio
- Actelion
- AdaptImmune
- Advanced Scientifics
- Advicenne
- Aenova
- Aesica
- Affymetrix
- Agilent Technologies
- Agricultural Technology
- Akcea Therapeutics
- Alcami
- Alcor
- Alfa Aesar
- Alkahest
- Alligator Bioscience
- Almac
- Ambrosia
- Amgen
- AMRI
- Annexin Pharmaceuticals
- Applied Genetic Technologies
- Applikon
- argenx
- Arysta LifeScience
- AstraZeneca
- Asymptote
- Athenex
- Atomwise
- Avacta
- Avalanche Biotechnologies
- Avenue Therapeutics
- AveXis
- Avitide
- AzurRx
- Baxalta
- Bayer
- Bayer CropScience
- BD Biosciences
- Beckman Coulter
- Benevolent AI
- Berg Health
- BerGenBio
- Bio-Rad
- Bio-Techne
- Bioarctic B
- Biogen
- BioHaven Pharma
- Bioinformatics
- Biomanufacturing
- Biomarin
- BioOutsource
- Biopharma
- Bioproduction
- BioReliance
- Biotech
- bluebird bio
- Boehringer Ingelheim
- Bonesupport
- Bristol-Myers Squibb
- Cambrex
- Cancer Immunotherapy
- Capsugel
- CAR-T
- CardioCell
- Catalent
- Celgene
- Cell Line Engineering
- Cell Therapy
- Cell Therapy Ltd
- Cellectis
- Celsis International
- Celyad
- Cepheid
- Charles River Laboratories
- ChemChina
- Chemicals
- Clementia Pharmaceuticals
- Clinical Diagnostics
- Clinical Trials
- CMC Biologics
- Cognizant Technology Solutions
- Consort Medical
- Corning
- Covance
- CR Pharma
- Crispr Therapeutics
- CRO/CMO
- Cryonics
- Daiichi Sankyo
- Danaher
- Deciphera Pharmaceuticals
- DeCODE Genetics
- Deloitte
- Denali Therapeutics
- Dendreon
- Diagnostics
- Downstream Processing
- Drug Development
- eGenesis
- Eli Lilly
- Elsevier
- EMD Millipore
- Entegris
- Eris Lifesciences
- Erytech Pharma
- Evidera
- Evolution Global Press Releases
- Evolution Infographics
- Evotec
- Exscientia
- FEI Company
- FiberCell Systems
- FIT Biotech
- Flow Cytometry
- Fosun Pharma
- Fujifilm Diosynth
- G-CON Manufacturing
- G1 Therapeutics
- GE Healthcare
- Gene Therapy
- Genentech
- Genomics & Proteomics
- GenSight Biologics
- Genzyme
- Gilead
- GlaxoSmithKline
- Glycotope
- Google Life Sciences
- Gore
- GSK
- Healthcare Analytics
- IBM
- ICON plc
- Idorsia
- Illumina
- Immunocore
- Immuron
- INC Research
- InDex Pharma
- Inflarx
- Informatics & Analytics
- Infosys
- InSilico Medicine
- InSphero
- inVentiv Health
- Invesco
- IP Group
- Isofol Medical
- JHL Biotech
- JM Separations
- Johnson & Johnson
- Juno Therapeutics
- Juvenescence AI
- Kala Pharmaceuticals
- Kantar Health
- Kerry Group
- KITE Pharma
- KIYATEC
- KrioRus
- Krystal Biotech
- KuBio
- Leica Biosystems
- Life Sciences
- Lion Biotechnologies
- Living Cell Technologies
- Lonza
- McKinsey
- Medical Devices
- Medimmune
- Medivation
- MeiraGTx
- Meissner
- Merck
- Mergers Partnerships & Acquisitions
- Mersana Therapeutics
- Mesoblast
- Metagenomics
- MilliporeSigma
- Modular Factories
- Molecular Pathology
- Monsanto
- Motif Bio
- Mustang Bio
- Myovant Sciences
- Myriad Genetics
- N4 Pharma
- NantKwest
- Natrix Separations
- Navigo Proteins
- Next Generation Sequencing
- Nightstar Therapeutics
- Ningbo Menovo
- Northwest Biotherapeutics
- Nortis
- Novartis
- Novo Nordisk
- NuCana
- Octapharma
- Organovo
- Orphazyme
- Ovid Therapeutics
- Oxford Genetics
- Oxford Nanopore
- Oxford University
- Pacific Biosciences
- Pall
- Parexel
- Patheon
- PerkinElmer
- Pfizer
- Pharmaron
- Plant Impact
- PPD
- Precision Medicine
- Press Ganey
- Prometic Bioseparations
- Promore Pharma
- Puridify
- Qiagen
- QuantiHealth
- Quintiles IMS
- RA Pharmaceuticals
- Regenerative Medicine
- Regeneron
- Repligen
- Roche
- RTI Health Solutions
- Samsung BioLogics
- Sangamo Therapeutics
- Saniona
- Sanofi
- Sartorius Stedim
- Scandinavian Chemotech
- Scarab Genomics
- Seragon
- Shire
- Siegfried
- Sienna Biopharmaceuticals
- Sigma-Aldrich
- Singulex
- SkinBioTherapeutics
- Spark Therapeutics
- Spinout
- Statis Systems
- Stem Cells
- StemoniX
- Stempeutics
- Sudhin Biopharma
- Sunovion Pharma
- Symphony Health Solutions
- Syngenta
- Synthon
- SynVivo
- Takara
- Tanvex BioPharma
- TARA
- Telix Pharma
- Terumo
- Teva Pharmaceuticals
- Texcell
- The Cryonics Institute
- The Future of BioManufacturing
- Theranexus
- Thermo Fisher Scientific
- Thomson Reuters
- TiGenix
- Tocagen
- TOSOH Bioscience
- Touchstone Innovations
- Toxicology
- Truven
- UCB Pharma
- Urogen Pharma
- Valbiotis
- Valeant Pharmaceuticals
- Venture Capital Investment
- Vericel
- Verona Pharma
- Vetter
- Virology
- ViroMed
- Vivo Science
- Wacker
- Waters
- Woodford Fund
- Wuxi Apptec
- WuXi NextCODE
- WuXi PharmaTech
- Xbrane Biopharma
- Xenotransplantation
- Xspray Pharma
- Zai Lab
- Zealand Pharma
- ZellWerk
- Zymeworks
About Us
Evolution Bioscience is a global consultancy firm, specialising in market intelligence, strategy formulation, technology transfer and commercialisation services, covering the full range of Biotechnology sectors.Get In Touch
+44 141 248 2026
Recent Posts
BROWSE NEWS BY INDUSTRY
Agricultural Technology
Biopharma
Bioproduction
Biotech
Cancer Immunotherapy
Cell Therapy
Chemicals
CRO/CMO
Diagnostics
Drug Development
Gene Therapy
Genomics & Proteomics
Informatics & Analytics
Life Sciences
Medical Devices
Mergers Partnerships & Acquisitions
Metagenomics
Next Generation Sequencing
Regenerative Medicine
The Future of BioManufacturing
BROWSE NEWS BY COMPANY
2016 © Evolution Bioscience / Darwin Hutton Partners
Recent Comments